The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK inhibitors.

—Clinicians may be underestimating the cognitive burden on patients with MS, underscoring the need for more comprehensive cognitive assessments and assessing patient-reported outcomes. A growing body ...

A brain protein called ANO2 has emerged as a new piece of the puzzle linking Epstein-Barr virus (EBV) infections and MS ...

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

A generic version of multiple sclerosis drug Copaxone was introduced in 2015, but it has done little to lower drug costs for MS patients, NPR reported. Yearly costs for MS drugs can run as high as $50 ...

Resistance training is effective for improving gait speed in individuals with multiple sclerosis. The intensity and duration of resistance training are important factors in determining the magnitude ...

A comprehensive look into MS treatment objectives is provided. Ryan Haumschild, PharmD, MS, MBA: In your thoughts, what are the outcomes that patients with multiple sclerosis [MS] are most interested ...

Mar. 23 -- FRIDAY, May 4 (HealthDay News) -- The drug rituximab reduces disease activity in people with the relapsing-remitting form of multiple sclerosis (MS), according to two new studies. Rituximab ...

There is no increased relapse risk in patients with multiple sclerosis (MS) and comorbid cancer who are receiving immune checkpoint inhibitor (ICI) therapy, results of a small study suggest. MS ...

Sarah Reeve, who is living with multiple sclerosis, says her perspective in life is "focusing on what she can do, and not what she cannot do" A woman living with multiple sclerosis (MS) has shared how ...

NATIONAL HARBOR, Maryland — Though evidence is mounting that low vitamin D levels may increase risk for the development and perhaps progression of multiple sclerosis, clinicians still do not have ...

BUFFALO, N.Y. — In recent years, new drugs to treat multiple sclerosis have significantly improved both the quality of life and longevity for patients with MS. Many of them now live well into their ...